What is NDC 68083-696?

68083-696 is the product NDC for Buprenorphine hydrochloride, Buprenorphine hydrochloride .324 mg/mL injection, listed with the FDA by Gland Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Gland Pharma Limited, NDC labeler code 68083. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Buprenorphine hydrochloride?

12 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Buprenorphine hydrochloride NDC 68083-696

NDC codes

FDA NDC Directory

Product NDC (as listed)68083-696Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68083-0696Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68083-696-05	6808306960568083069605	5 VIAL in 1 CARTON (68083-696-05) / 1 mL in 1 VIALMarketed from Oct 15, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Buprenorphine hydrochloride
Generic name (nonproprietary): buprenorphine hydrochloride
Active ingredients: Buprenorphine hydrochloride — .324 mg/mL
Dosage form: Injection
Route: Intramuscular, Intravenous
Labeler: Gland Pharma LimitedNDC labeler code 68083
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 221145
Marketing start: Oct 15, 2026
Listing expires: Dec 31, 2027
DEA schedule: CIII
Other FDA classes: Partial Opioid Agonists (Mechanism)
Identifiers: Product ID 68083-696_47e07da7-bfd9-42ea-89dd-b814f546add3SPL ID 47e07da7-bfd9-42ea-89dd-b814f546add3
Pharmacologic class: Partial Opioid Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N468083069605 followed by a unit qualifier and the quantity

Package 68083-0696-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 68083-696

What is NDC 68083-696?: 68083-696 is the product NDC for Buprenorphine hydrochloride, Buprenorphine hydrochloride .324 mg/mL injection, listed with the FDA by Gland Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Buprenorphine hydrochloride.
What is the active ingredient?: Buprenorphine hydrochloride.
Who is the labeler?: Gland Pharma Limited, NDC labeler code 68083. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Buprenorphine hydrochloride?: 12 other product NDCs are listed under this name. See all Buprenorphine hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Buprenorphine hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
buprenorphine hydrochloride	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	REMEDYREPACK INC.	70518-4570	70518-4570-00
buprenorphine hydrochloride	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	REMEDYREPACK INC.	70518-4571	70518-4571-0070518-4571-02
buprenorphine hydrochloride	Buprenorphine hydrochloride 12 mg/1	TabletSublingual	Advagen Pharma Ltd	72888-510	72888-0510-0172888-0510-02
Buprenorphine Hydrochloride	Buprenorphine hydrochloride .324 mg/mL	InjectionIntramuscular, Intravenous	Somerset Therapeutics, LLC	70069-027	70069-0027-05
buprenorphine hydrochloride	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	PAI Holdings, LLC dba PAI Pharma	0121-1019	00121-1019-30
buprenorphine hydrochloride	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	PAI Holdings, LLC dba PAI Pharma	0121-2038	00121-2038-30
buprenorphine hydrochloride	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	A-S Medication Solutions	50090-7559	50090-7559-00
Buprenorphine Hydrochloride	Buprenorphine hydrochloride .324 mg/mL	InjectionIntramuscular, Intravenous	Par Health USA, LLC	42023-179	42023-0179-05
buprenorphine hydrochloride	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	Advagen Pharma Ltd	72888-182	72888-0182-3072888-0182-90
buprenorphine hydrochloride	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	Advagen Pharma Ltd	72888-183	72888-0183-3072888-0183-90

All 13 Buprenorphine hydrochloride NDCs